5 Best Healthcare Stocks To Buy Now

3. Horizon Therapeutics Public Limited Company (NASDAQ:HZNP)

Number of Hedge Fund Holders: 77

Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) is a Dublin, Ireland-based biopharmaceutical company. In December, Amgen Inc. (NASDAQ:AMGN) reached an agreement to acquire Horizon Therapeutics Public Limited Company (NASDAQ HZNP) for $116.50 per share in cash. This deal valued the biotech company at approximately $27.8 billion. However, the deal hit a snag after the US Federal Trade Commission (FTC) decided to file a lawsuit in federal court. The FTC claims that a proposed deal between the two parties could cause monopoly concerns as Amgen Inc. (NASDAQ:AMGN) could use the rebates on its existing blockbuster drugs to pressurize health insurance companies into favouring the use of Horizon Therapeutics Public Limited Company’s (NASDAQ:HZNP) monopoly products in the treatment of thyroid eye disease and refractory gout.

Citadel Investment Group was the leading hedge fund investor in Horizon Therapeutics Public Limited Company (NASDAQ:HZNP) during Q1 2023. The hedge fund raised its stake in the company by over 200% during the first quarter of the year.